4//SEC Filing
Vizirgianakis Stavros G. 4
Accession 0001235802-22-000107
CIK 0001453593other
Filed
Aug 25, 8:00 PM ET
Accepted
Aug 26, 4:39 PM ET
Size
5.8 KB
Accession
0001235802-22-000107
Insider Transaction Report
Form 4
Vizirgianakis Stavros G.
Director
Transactions
- Award
Common Stock, $0.000001 par value
2022-08-25+70,776→ 3,585,855 total
Footnotes (3)
- [F1]These shares are subject to restricted stock unit awards granted under the Xtant Medical Holdings, Inc. Amended and Restated 2018 Equity Incentive Plan, and vest and become issuable on August 15, 2023, conditioned upon the Reporting Person remaining a director of Xtant through the vesting date.
- [F2]Includes 70,776 shares to be issued upon vesting pursuant to a restricted stock unit award granted under the Xtant Medical Holdings, Inc. Amended and Restated 2018 Equity Incentive Plan, conditioned upon the reporting person remaining a director of Xtant through the vesting date.
- [F3]Includes 3,515,079 shares issued in connection with the first closing of the private placement (the "Private Placement") pursuant to the securities purchase agreement by and among Xtant Medical Holdings, Inc. and several accredited investors. Does not include 2,264,861 shares to be issued in connection with the second closing of the Private Placement, which will be issued subject to the satisfaction of certain closing conditions.
Documents
Issuer
Xtant Medical Holdings, Inc.
CIK 0001453593
Entity typeother
Related Parties
1- filerCIK 0001559834
Filing Metadata
- Form type
- 4
- Filed
- Aug 25, 8:00 PM ET
- Accepted
- Aug 26, 4:39 PM ET
- Size
- 5.8 KB